MB "Farmalita" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
37,414 |
- |
463 |
440 |
- |
0.10 |
0.02 |
100.00 |
1.18 |
3,791 |
84 |
0 |
3,875 |
2023 |
---|
45,439 |
- |
1,875 |
1,781 |
- |
0.12 |
0.02 |
100.00 |
3.92 |
5,572 |
94 |
0 |
5,666 |
2024 |
---|
58,059 |
- |
17,260 |
16,397 |
- |
0.09 |
0.45 |
100.00 |
28.24 |
4,969 |
2,212 |
0 |
7,181 |
Register and
explore Okredo data2024 |
---|
58,059 |
- |
17,260 |
16,397 |
- |
0.09 |
0.45 |
100.00 |
28.24 |
4,969 |
2,212 |
0 |
7,181 |
Register and
explore Okredo data2024
Turnover (€)
58,059 €28 % *
Sales per employee (€)
-Profit before tax (€)
17,260 €821 % *
Net Profit (€)
16,397 €821 % *
Profit per employee (€)
-Working capital requirement
0.09 -25.00 % *
Debt-to-equity ratio
0.45 2,150.00 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
28.24 %620.41 % *
Equity (€)
4,969 €-11 % *
Amounts Payable And Liabilities (€)
2,212 €2,253 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
7,181 €27 % *